Myelodysplastic Syndromes

• CLINICAL_TRIALS trial_result · 2007-04-23
  Clinical Trial Update: Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood [Phase 2]

  This is a Phase 2 trial update evaluating low-intensity conditioning and immunotherapy for high-risk blood cancers; the study has been termi…

• CLINICAL_TRIALS trial_result · 2007-04-04
  Clinical Trial Update: Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200 [Phase 2]

  Phase 2 trial evaluating low-dose thalidomide for myelodysplastic syndromes has completed. No efficacy or safety results are provided in thi…

• CLINICAL_TRIALS trial_result · 2007-03-12
  Clinical Trial Update: Lenalidomide in Subjects With intermediate2 or High MDS Associated With a Deletion (DEL) 5q [31] [Phase 2]

  Phase 2 clinical trial evaluating lenalidomide in patients with intermediate-2 or high-risk myelodysplastic syndromes associated with deleti…

• CLINICAL_TRIALS trial_result · 2006-11-01
  Clinical Trial Update: Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS) [Phase 2]

  A Phase 2 trial update on high-dose pulse DN-101 (calcitriol) for patients with myelodysplastic syndromes.

• CLINICAL_TRIALS trial_result · 2006-10-26
  Clinical Trial Update: L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes [Phase 2]

  Phase 2 clinical trial of L-ascorbic acid depletion to treat acute myeloid leukemia and myelodysplastic syndromes is currently suspended.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.